Post-approval studies (Phase 4)Study completedNCT00934648
What this trial is testing
MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 15